Aurora Cannabis Inc (ACB) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.008x

Based on the latest financial reports, Aurora Cannabis Inc (ACB) has a cash flow conversion efficiency ratio of -0.008x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.45 Million) by net assets ($527.36 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ACB market cap for the company's overall valuation and market capitalisation.

Aurora Cannabis Inc - Cash Flow Conversion Efficiency Trend (2007–2026)

This chart illustrates how Aurora Cannabis Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Aurora Cannabis Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aurora Cannabis Inc ranked by their cash flow conversion efficiency. Explore ACB cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Canaan Inc
NASDAQ:CAN
-0.742x
Kalyani Investment Company Limited
NSE:KICL
-0.001x
Spectral Med Inc
TO:EDT
0.039x
Lubelski Wegiel Bogdanka S.A.
WAR:LWB
-0.020x
Eurobio Scientific SA
PA:ALERS
0.030x
Envipco Holding N.V.
AS:ENVI
0.047x
Chen Full International Co Ltd
TWO:8383
-0.006x
Tian Zheng International Precision Machinery Co Ltd
TWO:6654
-0.065x

Annual Cash Flow Conversion Efficiency for Aurora Cannabis Inc (2007–2026)

The table below shows the annual cash flow conversion efficiency of Aurora Cannabis Inc from 2007 to 2026. View ACB stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 $513.15 Million $-13.51 Million -0.026x -199.54%
2025-03-31 $605.09 Million $16.00 Million 0.026x +123.28%
2024-03-31 $602.92 Million $-68.51 Million -0.114x +30.76%
2023-03-31 $521.74 Million $-85.63 Million -0.164x +22.35%
2022-03-31 $521.74 Million $-110.27 Million -0.211x -104.26%
2021-03-31 $2.04 Billion $-210.58 Million -0.103x +36.06%
2020-03-31 $2.11 Billion $-342.14 Million -0.162x -270.73%
2019-03-31 $4.40 Billion $-192.25 Million -0.044x +16.43%
2018-03-31 $1.56 Billion $-81.67 Million -0.052x +14.22%
2017-03-31 $219.71 Million $-13.38 Million -0.061x +94.84%
2016-03-31 $5.74 Million $-6.77 Million -1.180x -36.07%
2015-03-31 $3.83 Million $-3.32 Million -0.867x -22.12%
2014-03-31 $1.36 Million $-965.11K -0.710x -9.48%
2013-03-31 $690.35K $-447.84K -0.649x -152.05%
2012-03-31 $1.08 Million $-277.98K -0.257x -28.38%
2011-03-31 $1.37 Million $-275.48K -0.200x -11027.01%
2010-03-31 $1.71 Million $-3.08K -0.002x +92.54%
2009-03-31 $1.62 Million $-39.04K -0.024x +53.41%
2008-03-31 $1.68 Million $-87.26K -0.052x -677.32%
2007-03-31 $1.68 Million $15.11K 0.009x --

About Aurora Cannabis Inc

NASDAQ:ACB USA Drug Manufacturers - Specialty & Generic
Market Cap
$270.33 Million
Market Cap Rank
#16022 Global
#3800 in USA
Share Price
$4.27
Change (1 day)
+5.96%
52-Week Range
$2.58 - $6.23
All Time High
$1416.62
About

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis… Read more